Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML).

被引：0
|
作者：
Chen, Yaozhu J.
Huang, Hui
Divino, Victoria
Pokras, Shibani
Hallinan, Shawn
Munakata, Julie
Taylor, Catherine
McGarry, Lisa
Ng, Daniel
Nieset, Christopher
Knopf, Kevin B.
机构：
[1] IMS Hlth, Alexandria, VA USA
[2] ARIAD Pharmaceut Inc, Cambridge, MA USA
[3] IMS Hlth, San Francisco, CA USA
[4] ARIAD, Cambridge, MA USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7091
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcomes of blast phase chronic myeloid leukemia (BP-CML) in the tyrosine kinase inhibitor (TKI) era.
    Talati, Chetasi
    Isenalumhe, Leidy Lismeri
    Shams, Samantha Reiter
    Kuykendall, Andrew Tucker
    Chavez, Julio C.
    Shah, Bijal D.
    Sweet, Kendra Lynn
    Pinilla-Ibarz, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] ADHERENCE TO TYROSINE KINASE INHIBITORS (TKI) IN CHRONIC MYELOID LEUKEMIA (CML) SEEMS TO BE RELATED TO DURATION OF TREATMENT AND TYPE
    De Almeida, M. H.
    Barbosa Pagnano, K. B.
    Sanches Souza, H. A.
    Souza, C. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 343 - 343
  • [23] THREE NEW MUTATIONS FOUND IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS RESISTANT TO TYROSINE KINASE INHIBITORS (TKI)
    Mascarenhas, C. Couto
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 572 - 572
  • [24] Adverse Prognosis Of Extramedullary Disease In Patients With Chronic Myeloid Leukemia (CML) In The Tyrosine Kinase Inhibitor (TKI) Era: a Cohort Study Of 283 Blastic Phase CML Patients
    Chae, Young Kwang
    Kantarjian, Hagop M.
    Baljevic, Muhamed
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Kadia, Tapan M.
    O'Brien, Susan
    Romo, Carlos G.
    Pierce, Sherry R.
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2013, 122 (21)
  • [25] Discontinuation of Tyrosine Kinase Inhibitor (TKI) Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in US Clinical Practice Following Updates to NCCN CML Practice Guidelines
    Atallah, Ehab
    Sadek, Islam
    Maegawa, Rodrigo
    Cao, Xiting
    Latremouille-Viau, Dominick
    Pivneva, Irina
    Rossi, Carmine
    Guerin, Annie
    Kota, Vamsi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S231 - S231
  • [26] JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment
    Kulemina, Olga
    Yakovleva, Julia
    Lazorko, Natalia
    Chitanava, Tamara
    Siordia, Nadia
    Shnalieva, Nadezhda
    Tochenaya, Elena
    Mateikovich, Polina
    Lomaia, Elza
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S343 - S344
  • [27] Outcomes of Chronic Phase Chronic Myeloid Leukemia (CP-CML) after Sequential Treatment with Tyrosine Kinase Inhibitors (TKI)
    Kong, Jee Hyun
    Winton, Elliott F.
    Heffner, Leonard
    Gaddh, Manila
    Hill, Brittany
    Arellano, Martha L.
    El-Rassi, Fuad
    Kim, Audrey
    Kota, Vamsi
    BLOOD, 2017, 130
  • [28] A Global Retrospective and Physician-Based Analysis of Adherence to Tyrosine Kinase Inhibitor (TKI) Therapies for Chronic Myeloid Leukemia (CML).
    Guilhot, Francois
    Coombs, John
    Zernovak, Oleg
    Szczudlo, Tomasz
    Rosti, Gianantonio
    BLOOD, 2010, 116 (21) : 644 - 644
  • [29] Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
    Russo, Domenico
    Malagola, Michele
    Skert, Cristina
    Fili, Carla
    Bergonzi, Cesare
    Cancelli, Valeria
    Cattina, Federica
    CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 755 - 767
  • [30] Survival Impact of Patients (Pts) with Chronic Myeloid Leukemia (CML) Due to Failure from the Use of One or More Tyrosine Kinase Inhibitors (TKI)
    Akosile, Mary
    Pierce, Sherry
    Brandt, Mark
    Verstovsek, Srdan
    Borthakur, Gautam
    Kantarjian, Hagop
    Ravandi, Farhad
    Wierda, William
    Garcia-Manero, Guillermo
    Daver, Naval
    Kadia, Tapan
    Burger, Jan A.
    Pemmaraju, Naveen
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2015, 126 (23)
12345